The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia

Therapeutic Apheresis

Volumn 1, Issue 3, 1997, Pages 260-270

  Koga, Nobuhiko ^a  

^a Koga Hospital   (Japan)

Author keywords

B mode ultrasonography; Carotid atherosclerosis; Coronary angiography; Intima media thickness; Low density lipoprotein apheresis

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOCARDIOGRAPHY; APHERESIS; ARTERIOSCLEROSIS; BLOOD; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DISEASE COURSE; ECHOGRAPHY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; PATHOLOGY; RADIOGRAPHY; REVIEW; TREATMENT OUTCOME;

ARTERIOSCLEROSIS; BLOOD COMPONENT REMOVAL; CAROTID ARTERY DISEASES; CHOLESTEROL, LDL; CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DISEASE PROGRESSION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; TREATMENT OUTCOME;

EID: 0031195869     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00149.x     Document Type: Article

References (33)

1. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y, for the LARS investigators. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. Atherosclerosis 1992;95: 1-13.
2. Koga N, Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991;90:9-21.
3. Nishimura S, Yamaguchi H, L-CAPS groups investigators. Regression of coronary atherosclerosis by intensive lipid-lowering therapy with combined LDL-apheresis and drugs in familial hypercholesterolemia: Japan LDL-Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS). Circulation 1994;90(Suppl 1):510.
4. Michishita I, Thompson GR. Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion system. Atherosclerosis 1991;88:203-11.
5. Kano M, Koizumi J, Jadhav A, Thompson GR. Plasma exchange and low density lipoprotein apheresis in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 1987;7: 256-61.
6. Leitinger N, Pirich C, Blazek I, Endler G, Sinzinger H. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment. Atherosclerosis 1996;126:305-12.
7. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese C, Mancini M. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 1990;81:610-6.
8. Uno H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K, Yano K. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance. Atherosclerosis 1995;116: 93-102.
9. Sinzinger H, Pirich C, Bednar J, O'Grady J. Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis. Thromb Res 1996;82: 291-301.
10. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341:1496-1500.
11. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89: 2519-24.
12. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
13. Igarashi K, Horimoto M, Takenaka T, Inoue H, Miyata S. Acute cholesterol lowering therapy with LDL-apheresis improves endothelial function of the coronary microcirculation in patients with hypercholesterolemia. Circulation 1995; 92(8):452.
14. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
15. Thompson GR, Maher VMG, Matthews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, Feyter P, Henderson A. Familial hypercholesterolaemia regression study: A randomized trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-6.
16. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin J-T, Kaplan C, Zhao X-Q, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
17. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-9.
18. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LWV, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ, the MARS research group. Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993;119:969-76.
19. Waters D, Higginson L, Gladstone P, Kimball B, May ML, Boccuzzi SJ, Lesperance J, the CCAIT study group. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 1994;89:959-68.
20. MAAS Investigators. Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344:633-8.
21. Kroon AA, Aengevaeren WRM, van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG, Stalenhoef AFH. LDL-Apheresis Atherosclerosis Regression Study (LAARS): Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93: 1826-35.
22. Brankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
23. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of colestipolniacin on coronary atherosclerosis: A 4-year follow-up. JAMA 1990;264:3013-7.
24. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, Sawin HR Jr, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC, the POSCH group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the Program on Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990;323:946-55.
25. Alderman EL, Haskell WL, Fair JM, Superko HR, Maron DJ, Champagne MA, Mackey SF, Williams PT, Krauss RM, Farquhar JW, the SCRIP staff. Beneficial angiographic and clinical response to multicenter modification in the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1991;84(Suppl 2):140.
26. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-91.
27. Takegoshi T, Kitoh C, Shimada T, Hirai J, Haba T, Wakasugi T, Saga T, Yamazaki Y, Koizumi J, Mabuchi H. Evidence for regression of coronary atherosclerosis effected by LDL-apheresis in a patient with familial hypercholesterolemia. (Abstract). Atherosclerosis 1994;109:160.
28. Koga N, Kochi K. LDL apheresis and improvement in the coronary arterial stenosis of hypercholesterolemic patients - evaluation by computerized quantitative coronary angiography. Jpn J Therapy 1988;70:158-164.
29. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991;11:1786-94.
30. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993;13:1404-11.
31. Keller CH, Spengel FA. Changes of atherosclerosis of the carotid arteries due to severe familial hypercholesterolemia following long-term plasmapheresis, assessed by duplex scan. Klin Wochenschr 1988;66:149-152.
32. Kennend M, Kleophas W, Gries FA. Regression of carotid plaques during low density lipoprotein cholesterol elimination. Stroke 1991;22:989-92.
33. Crouse JR III, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995;75:455-9.